-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IhjHd5eUPOpoOoai1AR5m3ODClHGJXtTl04iYwPqdAG8vVRVn9WYwuNp8ywqdFvF fAvFaYf0GmuOeB+e9grATA== 0001179110-04-019280.txt : 20041004 0001179110-04-019280.hdr.sgml : 20041004 20041004163319 ACCESSION NUMBER: 0001179110-04-019280 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20040930 FILED AS OF DATE: 20041004 DATE AS OF CHANGE: 20041004 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: BESSLER ANITA CENTRAL INDEX KEY: 0001204545 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-15525 FILM NUMBER: 041062916 BUSINESS ADDRESS: STREET 1: C/O EDWARDS LIFESCIENCES CORP STREET 2: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: EDWARDS LIFESCIENCES CORP CENTRAL INDEX KEY: 0001099800 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 364316614 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 BUSINESS PHONE: 9492502500 MAIL ADDRESS: STREET 1: ONE EDWARDS WAY CITY: IRVINE STATE: CA ZIP: 92614 FORMER COMPANY: FORMER CONFORMED NAME: CVG CONTROLLED INC DATE OF NAME CHANGE: 19991126 4 1 edgar.xml FORM 4 - X0202 4 2004-09-30 0 0001099800 EDWARDS LIFESCIENCES CORP EW 0001204545 BESSLER ANITA C/O EDWARDS LIFESCIENCES CORPORATION; ONE EDWARDS WAY IRVINE CA 92614 0 1 0 0 Corp VP, Global Franchise Mgmt Common Stock 3788 I By 401(k) Employee Stock Option (Right to Acquire) 8.375 2004-09-30 4 A 0 107 0 A 2005-03-30 2014-09-30 Common Stock 107 107 D Shares represented on the most recent statement of the 401(k) Plan Administrator where a unitized accounting procedure is utilized to convert the equities to share equivalents. This Form 4 reflects changes in beneficial ownership only; it does not identify other securities of the Issuer beneficially owned by the reporting person. This option was granted pursuant to the Edwards Lifesciences Corporation Executive Option Plan. The executive officer receives an option in lieu of forgone compensation under a formula where forgone compensation equals 75%, and the exercise price indicated equals 25%, of the fair market value per share on the grant date. The exercise price may be increased to include an additional amount representing the cost of capital as determined by Edwards. The option becomes exercisable six months after the grant date. /s/ Jay P. Wertheim, Attorney-in-fact 2004-10-04 -----END PRIVACY-ENHANCED MESSAGE-----